Elaine K. Sorg - 23 Aug 2021 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role
SVP, US Commercial Operations
Signature
Steven L. Scrogham, attorney-in-fact for Elaine K. Sorg
Issuer symbol
ABBV
Transactions as of
23 Aug 2021
Transactions value $
-$759,931
Form type
4
Filing time
25 Aug 2021, 18:08:43 UTC
Next filing
14 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABBV Common Stock, $0.01 par value Sale -$720K -6K -34.1% $120.00 11.6K 23 Aug 2021 Direct
transaction ABBV Common Stock, $0.01 par value Options Exercise $810K +7.08K +61.06% $114.36 18.7K 23 Aug 2021 Direct
transaction ABBV Common Stock, $0.01 par value Sale -$850K -7.08K -37.91% $120.00 11.6K 23 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABBV Option (Right to buy) Options Exercise $0 -7.08K -100% $0.00* 0 23 Aug 2021 Common Stock 7.08K $114.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

The transactions reported on this Form 4 were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).